Mar 16 0 3 Keys to Unlocking Rare Disease Markets By Rare Collective | David Lapidus | No Comments What is a rare disease therapy worth? David Lapidus discusses this pivotal question for pharmaceutical companies. Read More
Mar 02 1 United by Rare: A Defining Week for Rare Diseases By Rare Collective | Chris Smith, Rare Collective | No Comments At a time of divided politics and diverse opinions, easing the burden of rare diseases is emerging as a cause that everyone can understand and support. Read More